NCT05246358 is a NA clinical trial of ChoniSense Polso in Respiratory Rate, sponsored by ChroniSense Medical Ltd..

Who is sponsoring NCT05246358?

NCT05246358 is sponsored by ChroniSense Medical Ltd..

What drugs are being tested in NCT05246358?

Interventions in NCT05246358: ChoniSense Polso.

What condition does NCT05246358 study?

NCT05246358 studies Respiratory Rate.

Is NCT05246358 still recruiting?

NCT05246358 is currently completed. Last updated 18 February 2022.

Last reviewed 2022-02-18 · How we verify

NCT05246358

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Respiratory Rate Validation Study - ChroniSense Polso

Completed NA Last updated 18 February 2022

What this trial tests

NA trial testing ChoniSense Polso in Respiratory Rate in 20 participants. Completed in 11 June 2021.

Timeline

10 May 2021

Primary endpoint
14 May 2021

11 June 2021

Quick facts

Lead sponsor	ChroniSense Medical Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	10 May 2021
Primary completion	14 May 2021
Estimated completion	11 June 2021
Sites	1 location across United States

Drugs / interventions tested

ChoniSense Polso

Conditions studied

Respiratory Rate — all drugs for Respiratory Rate →

Sponsor

ChroniSense Medical Ltd.

Who can join

Adults 18 to 52, any sex, with Respiratory Rate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

20 volunteer test subjects entered into an accuracy study that is designed to validate accuracy of the respiratory rate of the ChroniSense Polso

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Rate

Currently open trials in the same condition.

NCT05451875 — Validation of Vital Signs Recording With VT-Patch Connected Devices in Children · recruiting
NCT05022264 — Remote Investigation and Assessment of Vital Signs · recruiting
NCT03750318 — Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital · NA · active not recruiting

Other ChroniSense Medical Ltd. trials

Trials by the same sponsor.

NCT05735210 — Polso™ Watch Blood Pressure Accuracy With Blood Pressure Change Validation · NA · unknown
NCT03735329 — Polso SpO2 Accuracy Validation Study · NA · completed
NCT03750344 — ChroniSense Polso Wrist Worn Respiration Rate Validation Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05246358 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ChroniSense Medical Ltd.
Last refreshed: 18 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05246358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing